Activation of vasopressin neurons leads to phenotype progression in a mouse model for familial neurohypophysial diabetes insipidus

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 298, Issue 2, 2010, Pages

  Hiroi, Maiko ^a   Morishita, Yoshiaki ^a   Hayashi, Masayuki ^a   Ozaki, Nobuaki ^a   Sugimura, Yoshihisa ^a   Nagasaki, Hiroshi ^b   Shiota, Akira ^c   Oiso, Yutaka ^a   Arima, Hiroshi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c PhoenixBio USA Corporation   (Japan)

Author keywords

Aggregates; Hereditary disease

Indexed keywords

DESMOPRESSIN; MESSENGER RNA; VASOPRESSIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN NERVE CELL; CELL ACTIVATION; CELL ACTIVITY; CELL INCLUSION; CONTROLLED STUDY; DIABETES INSIPIDUS; DISEASE COURSE; DISEASE MODEL; FEMALE; GENE EXPRESSION; HETEROZYGOTE; HORMONE SYNTHESIS; IMMUNOHISTOCHEMISTRY; MALE; MINIPUMP; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SODIUM INTAKE; URINE OSMOLALITY; URINE VOLUME;

ANIMALS; DEAMINO ARGININE VASOPRESSIN; DIABETES INSIPIDUS, NEUROGENIC; DISEASE PROGRESSION; DRINKING; HEMATOCRIT; HYPOGLYCEMIC AGENTS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MICE; MICE, INBRED C57BL; NEURONS; OSMOLAR CONCENTRATION; PHENOTYPE; PITUITARY GLAND, POSTERIOR; SODIUM, DIETARY; URODYNAMICS; VASOPRESSINS;

EID: 75449096144     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00529.2009     Document Type: Article

References (44)

1. Arima H, Kondo K, Kakiya S, Nagasaki H, Yokoi H, Yambe Y, Murase T, Iwasaki Y, Oiso Y. Rapid and sensitive vasopressin heteronuclear RNA responses to changes in plasma osmolality. J Neuroendocrinol 11: 337-341, 1999.
2. Bisset GW, Chowdrey HS. Control of release of vasopressin by neuroendocrine reflexes. Q J Exp Physiol 73: 811-872, 1988.
3. Bourque CW. Central mechanisms of osmosensation and systemic osmoregulation. Nat Rev Neurosci 9: 519-531, 2008.
4. Brunner DB, Burnier M, Brunner HR. Plasma vasopressin in rats: effect of sodium, angiotensin, and catecholamines. Am J Physiol Heart Circ Physiol 244: H259-H265, 1983.
5. Burbach JP, De Hoop MJ, Schmale H, Richter D, De Kloet ER, Ten Haaf JA, De Wied D. Differential responses to osmotic stress of vasopressin-neurophysin mRNA in hypothalamic nuclei. Neuroendocrinology 39: 582-584, 1984.
6. Burbach JP, Luckman SM, Murphy D, Gainer H. Gene regulation in the magnocellular hypothalamo-neurohypophysial system. Physiol Rev 81: 1197-1267, 2001.
7. Carlson SH, Beitz A, Osborn JW. Intragastric hypertonic saline increases vasopressin and central Fos immunoreactivity in conscious rats. Am J Physiol Regul Integr Comp Physiol 272: R750-R758, 1997.
8. Carter DA, Murphy D. Independent regulation of neuropeptide mRNA level and poly(A) tail length. J Biol Chem 264: 6601-6603, 1989.
9. Chen L, Feany MB. α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Nat Neurosci 8: 657-663, 2005.
10. Chitturi S, Harris M, Thomsett MJ, Bowling F, McGown I, Cowley D, Leong GM, Batch J, Cotterill AM. Utility of AVP gene testing in familial neurohypophyseal diabetes insipidus. Clin Endocrinol (Oxf) 69: 926-930, 2008.
11. Christensen JH, Rittig S. Familial neurohypophyseal diabetes insipidus - an update. Semin Nephrol 26: 209-223, 2006.
12. Cowley AW Jr, Skelton MM, Merrill DC, Quillen EW Jr, Switzer SJ. Influence of daily sodium intake on vasopressin secretion and drinking in dogs. Am J Physiol Regul Integr Comp Physiol 245: R860-R872, 1983.
13. Edwards CR, Kitau MJ, Chard T, Besser GM. Vasopressin analogue DDAVP in diabetes insipidus: clinical and laboratory studies. Br Med J 3: 375-378, 1973.
14. Grant FD, Ahmadi A, Hosley CM, Majzoub JA. Two novel mutations of the vasopressin gene associated with familial diabetes insipidus and identification of an asymptomatic carrier infant. J Clin Endocrinol Metab 83: 3958-3964, 1998.
15. Hayashi M, Arima H, Ozaki N, Morishita Y, Hiroi M, Nagasaki H, Kinoshita N, Ueda M, Shiota A, Oiso Y. Progressive polyuria without vasopressin neuron loss in a mouse model for familial neurohypophysial diabetes insipidus. Am J Physiol Regul Integr Comp Physiol 296: R1641-R1649, 2009.
16. Heer M, Baisch F, Kropp J, Gerzer R, Drummer C. High dietary sodium chloride consumption may not induce body fluid retention in humans. Am J Physiol Renal Physiol 278: F585-F595, 2000.
17. Hetz C, Russelakis-Carneiro M, Walchli S, Carboni S, Vial-Knecht E, Maundrell K, Castilla J, Soto C. The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity. J Neurosci 25: 2793-2802, 2005.
18. Hirayama A, Fujimoto K, Akiyama T, Hirao Y. Decrease in nocturnal urinary levels of arginine vasopressin in patients with nocturnal polyuria. Urology 68: 19-23, 2006.
19. Hoekstra JA, van Lieburg AF, Monnens LA, Hulstijn-Dirkmaat GM, Knoers VV. Cognitive and psychosocial functioning of patients with congenital nephrogenic diabetes insipidus. Am J Med Genet 61: 81-88, 1996.
20. Kjeldsen SE, Forsberg G, Eide I, Aakesson I, Os I, Skjoto J, Frederichsen P. Dietary sodium intake and vasopressin excretion in man. J Hypertens Suppl 2: S301-S303, 1984.
21. Majzoub JA, Rich A, van Boom J, Habener JF. Vasopressin and oxytocin mRNA regulation in the rat assessed by hybridization with synthetic oligonucleotides. J Biol Chem 258: 14061-14064, 1983.
22. Majzoub JA, Srivatsa A. Diabetes insipidus: clinical and basic aspects. Pediatr Endocrinol Rev 4, Suppl 1: 60-65, 2006.
23. Makaryus AN, McFarlane SI. Diabetes insipidus: diagnosis and treatment of a complex disease. Cleve Clin J Med 73: 65-71, 2006.
24. McLeod JF, Kovacs L, Gaskill MB, Rittig S, Bradley GS, Robertson GL. Familial neurohypophyseal diabetes insipidus associated with a signal peptide mutation. J Clin Endocrinol Metab 77: 599A-599G, 1993.
25. Mundschenk J, Rittig S, Siggaard C, Hensen J, Lehnert H. A new mutation of the arginine vasopressin-neurophysin II gene in a family with autosomal dominant neurohypophyseal diabetes insipidus. Exp Clin Endocrinol Diabetes 109: 406-409, 2001.
26. Nagasaki H, Ito M, Yuasa H, Saito H, Fukase M, Hamada K, Ishikawa E, Katakami H, Oiso Y. Two novel mutations in the coding region for neurophysin-II associated with familial central diabetes insipidus. J Clin Endocrinol Metab 80: 1352-1356, 1995.
27. Naimi N, Rivest S, Racotta I, Richard D. Neuronal activation of the hypothalamic magnocellular system in response to oropharyngeal stimuli in the rat. J Neuroendocrinol 9: 329-340, 1997.
28. Oiso Y, Iwasaki Y, Kondo K, Takatsuki K, Tomita A. Effect of the opioid κ-receptor agonist U50488H on the secretion of arginine vasopressin. Study on the mechanism of U50488H-induced diuresis. Neuroendocrinology 48: 658-662, 1988.
29. Oliet SH, Bourque CW. Mechanosensitive channels transduce osmosensitivity in supraoptic neurons. Nature 364: 341-343, 1993.
30. Outeiro TF, Kontopoulos E, Altmann SM, Kufareva I, Strathearn KE, Amore AM, Volk CB, Maxwell MM, Rochet JC, McLean PJ, Young AB, Abagyan R, Feany MB, Hyman BT, Kazantsev AG. Sirtuin 2 inhibitors rescue α-synuclein- mediated toxicity in models of Parkinson's disease. Science 317: 516-519, 2007.
31. Paxinos G, Franklin KJ. The Mouse Brain in Stereotaxic Coordinates. New York: Academic, 2000.
32. Periquet M, Fulga T, Myllykangas L, Schlossmacher MG, Feany MB. Aggregated α-synuclein mediates dopaminergic neurotoxicity in vivo. J Neurosci 27: 3338-3346, 2007.
33. Repaske DR, Browning JE. A de novo mutation in the coding sequence for neurophysin-II (Pro24→Leu) is associated with onset and transmission of autosomal dominant neurohypophyseal diabetes insipidus. J Clin Endocrinol Metab 79: 421-427, 1994.
34. Repaske DR, Medlej R, Gultekin EK, Krishnamani MR, Halaby G, Findling JW, Phillips JA 3rd. Heterogeneity in clinical manifestation of autosomal dominant neurohypophyseal diabetes insipidus caused by a mutation encoding Ala-1→Val in the signal peptide of the arginine vasopressin/neurophysin II/copeptin precursor. J Clin Endocrinol Metab 82: 51-56, 1997.
35. Richard D, Bourque CW. Synaptic activation of rat supraoptic neurons by osmotic stimulation of the organum vasculosum lamina terminalis. Neuroendocrinology 55: 609-611, 1992.
36. Robertson GL. Posterior Pituitary. New York: McGraw-Hill, 1995.
37. Robinson AG, Roberts MM, Evron WA, Verbalis JG, Sherman TG. Hyponatremia in rats induces downregulation of vasopressin synthesis. J Clin Invest 86: 1023-1029, 1990.
38. Rutishauser J, Boni-Schnetzler M, Boni J, Wichmann W, Huisman T, Vallotton MB, Froesch ER. A novel point mutation in the translation initiation codon of the pre-pro-vasopressin-neurophysin II gene: cosegregation with morphological abnormalities and clinical symptoms in autosomal dominant neurohypophyseal diabetes insipidus. J Clin Endocrinol Metab 81: 192-198, 1996.
39. Si-Hoe SL, De Bree FM, Nijenhuis M, Davies JE, Howell LM, Tinley H, Waller SJ, Zeng Q, Zalm R, Sonnemans M, Van Leeuwen FW, Burbach JP, Murphy D. Endoplasmic reticulum derangement in hypothalamic neurons of rats expressing a familial neurohypophyseal diabetes insipidus mutant vasopressin transgene. FASEB J 14: 1680-1684, 2000.
40. Siggaard C, Rittig S, Corydon TJ, Andreasen PH, Jensen TG, Andresen BS, Robertson GL, Gregersen N, Bolund L, Pedersen EB. Clinical and molecular evidence of abnormal processing and trafficking of the vasopressin preprohormone in a large kindred with familial neurohypophyseal diabetes insipidus due to a signal peptide mutation. J Clin Endocrinol Metab 84: 2933-2941, 1999.
41. Singer I, Oster JR, Fishman LM. The management of diabetes insipidus in adults. Arch Intern Med 157: 1293-1301, 1997.
42. Stricker EM, Callahan JB, Huang W, Sved AF. Early osmoregulatory stimulation of neurohypophyseal hormone secretion and thirst after gastric NaCl loads. Am J Physiol Regul Integr Comp Physiol 282: R1710-R1717, 2002.
43. Stricker EM, Hoffmann ML, Riccardi CJ, Smith JC. Increased water intake by rats maintained on high NaCl diet: analysis of ingestive behavior. Physiol Behav 79: 621-631, 2003.
44. Tausch A, Stegner H, Leake RD, Artman HG, Fisher DA. Radioimmunoassay of arginine vasopressin in urine: development and application. J Clin Endocrinol Metab 57: 777-781, 1983.